JHU's Neurofibromatosis Therapeutic Acceleration Program celebrated the 10th anniversary of its Francis S. Collins Scholars ...

A new study led by Indiana University School of Medicine researchers revealed a potential strategy to address neurobehavioral ...

The new approval will help Merck make a return on its $3.9 billion investment in acquiring SpringWorks, which has operated as ...

The European Commission has approved EZMEKLY (mirdametinib) for treatment of symptomatic, inoperable plexiform neurofibromas ...

The event, hosted by NF Network, included a 5K walk/run, a basket raffle and a time to share and spread awareness ...

A new study led by Indiana University School of Medicine researchers revealed a potential strategy to address neurobehavioral ...